Home » Authors » Douglas Merrill

Douglas Merrill

Articles

ARTICLES

Wilex Begins Clinical Testing Of Product For Biliary Cancers

July 2, 2003

By Douglas Merrill

German Ministry Supports Biotech With Words, Funds

June 18, 2003

By Douglas Merrill

German Ministry Supports Biotech With Words, Funds

June 18, 2003

By Douglas Merrill

GPC Presents Promising Results From Oral Prostate Cancer Drug

June 4, 2003

By Douglas Merrill

Germany Companies Mtm, 4SC Each Completes EUR9M Financing

June 4, 2003

By Douglas Merrill

GPC Presents Promising Results From Oral Prostate Cancer Drug

June 4, 2003

By Douglas Merrill

Germany At Forefront Of Effort For International Cloning Ban

May 21, 2003

By Douglas Merrill

Germany At Forefront Of Effort For International Cloning Ban

May 21, 2003

By Douglas Merrill

Axaron Cutback To Focus On Stroke Reflects German Sector

May 14, 2003

By Douglas Merrill

Longtime U.S. Investor Adds Perspective To GLSV Venture

May 14, 2003

By Douglas Merrill

MUNICH, Germany - Is this the worst bear market he's ever seen in biotechnology? (BioWorld International)

View All Articles by Douglas Merrill

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....